Cargando…

T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G

Ewing sarcoma (EwS) is an aggressive mesenchymal cancer of bones or soft tissues. The mechanisms by which this cancer interacts with the host immune system to induce tolerance are not well understood. We hypothesized that the non-classical, immune-inhibitory HLA-molecule HLA-G contributes to immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spurny, Christian, Kailayangiri, Sareetha, Altvater, Bianca, Jamitzky, Silke, Hartmann, Wolfgang, Wardelmann, Eva, Ranft, Andreas, Dirksen, Uta, Amler, Susanne, Hardes, Jendrik, Fluegge, Maike, Meltzer, Jutta, Farwick, Nicole, Greune, Lea, Rossig, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814230/ https://www.ncbi.nlm.nih.gov/pubmed/29464090 http://dx.doi.org/10.18632/oncotarget.23815

Ejemplares similares

HLA-G and HLA-E Immune Checkpoints Are Widely Expressed in Ewing Sarcoma but Have Limited Functional Impact on the Effector Functions of Antigen-Specific CAR T Cells
por: Altvater, Bianca, et al.
Publicado: (2021)

Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
por: Rossig, Claudia, et al.
Publicado: (2018)

Overcoming Heterogeneity of Antigen Expression for Effective CAR T Cell Targeting of Cancers
por: Kailayangiri, Sareetha, et al.
Publicado: (2020)

Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma
por: Fuest, Sebastian, et al.
Publicado: (2022)

Surface expression of the immunotherapeutic target G(D2) in osteosarcoma depends on cell confluency
por: Wiebel, Malena, et al.
Publicado: (2021)

The Cellular Tumor Immune Microenvironment of Childhood Solid Cancers: Informing More Effective Immunotherapies
por: Holterhus, Malcolm, et al.
Publicado: (2022)

CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process
por: Altvater, Bianca, et al.
Publicado: (2023)

The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
por: Kailayangiri, S, et al.
Publicado: (2012)

Pelvic Ewing sarcoma: a retrospective outcome analysis of 104 patients who underwent pelvic tumor resection at a single supra-regional center
por: Guder, Wiebke K., et al.
Publicado: (2020)

Effect of Radiotherapy Dose on Outcome in Nonmetastatic Ewing Sarcoma
por: Kersting, Josephine, et al.
Publicado: (2023)

Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging
por: Liebsch, L, et al.
Publicado: (2013)

5-ALA-mediated fluorescence of musculoskeletal tumors in a chick chorio-allantoic membrane model: preclinical in vivo qualification analysis as a fluorescence-guided surgery agent in Orthopedic Oncology
por: Guder, Wiebke K., et al.
Publicado: (2022)

Secondary Malignancies after Ewing Sarcoma—Epidemiological and Clinical Analysis of an International Trial Registry
por: Kaiser, Isabelle, et al.
Publicado: (2022)

Focal adhesion kinase confers pro‐migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma
por: Steinestel, Konrad, et al.
Publicado: (2019)

Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
por: Zöllner, Stefan K., et al.
Publicado: (2021)

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Erber, Ramona, et al.
Publicado: (2021)

Analysis of drug sensitivity of human high-grade osteosarcoma in a chick chorioallantoic membrane (CAM) model: a proof of principle study
por: Guder, Wiebke K., et al.
Publicado: (2020)

SS18-SSX drives CREB activation in synovial sarcoma
por: Cyra, Magdalene, et al.
Publicado: (2022)

Dynamic prediction of overall survival: a retrospective analysis on 979 patients with Ewing sarcoma from the German registry
por: Liu, Chuchu, et al.
Publicado: (2020)

Proton Therapy for Primary Bone Malignancy of the Pelvic and Lumbar Region – Data From the Prospective Registries ProReg and KiProReg
por: Worawongsakul, Rasin, et al.
Publicado: (2022)

No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
por: Thiel, U., et al.
Publicado: (2021)

Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
por: Thiel, U., et al.
Publicado: (2021)

Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas
por: Kerkhoff, Maximilian, et al.
Publicado: (2023)

Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review
por: Haveman, Lianne M., et al.
Publicado: (2020)

Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma
por: Stork, Theresa, et al.
Publicado: (2021)

Differentially Expressed miRNAs in Ewing Sarcoma Compared to Mesenchymal Stem Cells: Low miR-31 Expression with Effects on Proliferation and Invasion
por: Karnuth, Bianca, et al.
Publicado: (2014)

Localized Ewing sarcoma of the tibia
por: Kashima, Takeshi G, et al.
Publicado: (2013)

Ewing Sarcoma as Secondary Malignant Neoplasm—Epidemiological and Clinical Analysis of an International Trial Registry
por: Zöllner, Stefan K., et al.
Publicado: (2022)

The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing Sarcoma
por: Haveman, Lianne M., et al.
Publicado: (2019)

Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor
por: Knowles, Helen J, et al.
Publicado: (2010)

Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy
por: Rehkämper, Jan, et al.
Publicado: (2018)

Gene expression profiling of Ewing sarcoma tumours reveals the prognostic importance of tumour–stromal interactions: a report from the Children's Oncology Group
por: Volchenboum, Samuel L., et al.
Publicado: (2015)

Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
por: Ohmura, Shunya, et al.
Publicado: (2021)

Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery
por: Bosma, S. E., et al.
Publicado: (2019)

Electrostatic anti-CD33-antibody–protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia
por: Bäumer, Nicole, et al.
Publicado: (2022)

Wound Healing in a Patient with Psoriasis Vulgaris and Femur Megaprosthesis Implantation
por: Nottrott, Markus, et al.
Publicado: (2008)

Bilateral Scapulothoracic Osteochondromas in a Patient With Hereditary Multiple Exostosis: A Case Report and Review of the Literature
por: Rupp, Markus, et al.
Publicado: (2016)

Reconstruction survival of segmental megaendoprostheses: a retrospective analysis of 28 patients treated for intercalary bone defects after musculoskeletal tumor resections
por: Streitbürger, Arne, et al.
Publicado: (2020)

Genomic EWS-FLI1 Fusion Sequences in Ewing Sarcoma Resemble Breakpoint Characteristics of Immature Lymphoid Malignancies
por: Berger, Manfred, et al.
Publicado: (2013)

The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
por: Berning, Philipp, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4dhpp3u2798tulk8d6jpb37u9u